AMONDYS 45
casimersen
Listed by Sarepta Therapeutics, Inc.
- Strength
- 50 mg/mL
- Form
- Injection
- Route
- Intravenous
- Class
- Antisense Oligonucleotide
What it contains
- Casimersen 50 mg/mL
FDA record
| Dosage form | Injection |
|---|---|
| Route | Intravenous |
| Drug class | Antisense Oligonucleotide |
| Approval route | NDA — original brand approval |
| NDC code | 60923-227 |
| FDA application | NDA213026 |
| RxNorm concept | 2480100 |
| Package sizes listed | 1 |
| Marketed since | February 2021 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.